- $63.77m
- $1.25bn
- $138.21m
- 47
- 74
- 22
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 116 | 123 | 123 | 130 | 138 |
Cost of Revenue | |||||
Gross Profit | 62.3 | 64.7 | 63.3 | 67.9 | 75.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 85.1 | 94.9 | 101 | 102 | 109 |
Operating Profit | 31.1 | 28 | 21.3 | 27.6 | 29.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.12 | -12.2 | -20 | -12.6 | -15.6 |
Net Income After Taxes | -4.12 | -12.2 | -20 | -12.6 | -15.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.67 | -4.91 | -7.59 | -4.76 | -5.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.98 | -5.38 | -8.24 | -5.73 | -7.19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.025 | -0.077 | -0.14 | -0.314 | -0.185 |
Dividends per Share |